News and Trends 20 Nov 2015
Cinfa Biotech’s Biosimilar is on the Starting Block!
Recently launched Cinfa Biotech just treated the first subjects in a clinical trial with its biosimilar of Neulasta®! Cinfa Biotech…
Biosimilars
- Latest Posts
News and Trends 10 Oct 2015
What Happened this Week? Nobel prize slips through CRISPR’s fingers, inside iGEM’s Jamboree and €120M boost for Alzheimer’s research
Monday: Manfred Horst on MSD, Biosimilars, KEYTRUDA and Merck & Co.’s rich history Tuesday: An Insider’s experience at the iGEM Giant Boston…
News and Trends 5 Oct 2015
Manfred Horst on MSD, Biosimilars, KEYTRUDA and his Company’s rich history
Manfred Horst is a Director Business Development Europe and working from an office at MSD France, the French affiliate of…
News and Trends 25 Sep 2015
Roche’s patent halts an Amgen biosimilar debut
Amgen has had great success with its Avastin biosimilar, used as an inhibitor of angiogenesis in tumor growth. However, despite…
ADVERTISEMENT
News and Trends 8 Jun 2015
Biosimilars will land in Poland thanks to a European loan
Biosimilars will have their Polish guarantor. Polpharma, the largest Polish producer of medicines, is the first benefactor of a €45M…
News and Trends 7 May 2015
Is the Biotech sector facing the issues of the Pharma Industry?
Currently, the pharma industry is going through a serious crisis, as the sector needs to review its economic model. On the…
News and Trends 28 Apr 2015
Will 2015 be the year of biosimilars?
The Biosimilar drug field is growing fast despite the tight regulatory, business and financial challenges it faces. The industry is forecasted to…
News and Trends 6 Mar 2015
Novartis achieves the First Biosimilar approval in US
The Novartis company Sandoz has become the first company with a biosimilar approved by the US Food and Drug Administration…
News and Trends 26 Feb 2015
Celltrion launches world’s first biosimilar monoclonal antibody in 12 new European markets
Celltrion Healthcare has today announced the launch of Remsima (infliximab) in 12 European markets: Austria, Belgium, Denmark, France, Germany, Greece,…
News and Trends 16 Sep 2014
The first insulin biosimilar has been approved in Europe
The European Commission granted marketing authorisation to Eli Lilly and Company and Boehringer Ingelheim for the first insulin biosimilar glargine…